IR Biosciences Holdings Inc.

IRBS · OTC
Analyze with AI
12/31/2010
12/31/2009
12/31/2008
12/31/2007
Operating Activities
Net Income-$5,278-$6,463-$5,807-$5,464
Dep. & Amort.$8$14$17$15
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC$1,883$76$45$504
Other Non-Cash$2,957$3,497$977$2,489
Operating Cash Flow-$430-$2,876-$4,769-$2,456
Investing Activities
PP&E Inv.$0-$2-$20-$25
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0-$2-$20-$25
Financing Activities
Debt Repay.$150$0$7,715-$50
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$11$0
Financing Cash Flow$150$0$7,726-$50
Forex Effect$0$0$0$0
Net Chg. in Cash-$280-$2,878$2,937-$2,531
Supplemental Information
Beg. Cash$280$3,158$221$2,752
End Cash$0$280$3,158$221
Free Cash Flow-$430-$2,878-$4,789-$2,481